Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,361–7,380 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

RomiPLOStim 700 MCG/ 1.4 ML SQ SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 675 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 1000 MG / 1000 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

RITUXAN 728 MG QS 728 mL 0.9% NACL IVPB; RITUXAN 560 MG / 306 ml 0.9% NACL; RITUXAN 562 MG IN 562 ml 0.9% NACL; RITUXAN 700 MG QS 700 mL 0.9% NACL IVPB; RITUXAN 1000 MG / 350 mL 0.9% NACL IVPB RITUXAN 730 MG / 730 mL 0.9% NACL IVPB; RITUXAN 1000 MG QS 1000 ml NS; RITUXAN 1000 MG QS 200 ml 0.9% NACL; RITUXAN 500 MG / 300 ml 0.9% NACL; RITUXAN 660 MG QS 660 ml 0.9% NACL; RITUXAN 770 MG QS 770 mL 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

REMICADE 680 MG QS 250 ML 0.9% NACL IVPB; REMICADE 270 MG QS 250 ML 0.9% NACL IV; REMICADE 730 MG QS 250 ML 0.9% NACL IVPB REMICADE 330 MG QS 250 ML 0.9% NACL IVPB; REMICADE 740 MG IN 250 ML NS IVPB; REMICADE 650 MG / 250 ml 0.9% NACL; REMICADE 1200 MG/250 ml 0.9% NACL IVPB; REMICADE 800 MG/250 ml 0.9% NACL IVPB REMICADE 600 MG / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

RAMUCIRUMAB 457 MG QS 250 ML NS IVPB; AMUCIRUMAB 1182 MG QS 250 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PRESERVATIVE FREE 0.9% NACL 5 ML SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PERTUZUMAB 840 MG/250 ml0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PERJETA 420 MG/250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB; PEMETREXED 490 MG /100 ml NS IVPB; PEMETREXED 800 mg/ 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PANITUMUMAB 400 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PEMBROLIZUMAB 200 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PACLITAXEL PROTEIN 175 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 190 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 355 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPB; PACLITAXEL ALBUMIN 160 MG / 100 ml NS IVPB; PACLITAXEL ALBUMIN 145 MG / 100 ml NS IVPB PACLITAXEL ALBUMIN 165 mg / 100 ml NS IVPB; PACLITAXEL ALBUMIN 150 mg /100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

PACLITAXEL 258 MG / 500 ML NS IVPB; PACLITAXEL 318 MG / 500 ML NS IVPB; PACLITAXEL 385 MG / 500 ML NS IVPB; PACLITAXEL 340 MG / 500 ML NS IVPB; PACLITAXEL 332 MG / 500 ML NS IVPB; PACLITAXEL 250 MG / 500 ML NS IVPB; PACLITAXEL 117 MG / 250 ML NACL 0.9% IVPB PACLITAXEL 90 MG / 250 ML NS IVPB; PACLITAXEL 290 MG / 500 ML NS IVPB; PACLITAXEL 168 MG / 250 ML NS IVPB; PACLITAXEL 157 MG / 250 ML NS IVPB; PACLITAXEL 350 MG / 500 ML NS IVPB; PACLITAXEL 280 mg / 500 ML NS IVPB; PACLITAXEL 282 mg / 500 ML NS IVPB; PACLITAXEL 90 MG / 250 ML D5W IVPB; PACLITAXEL 255 MG / 500 ML NS IVPB; PACLITAXEL 100 MG / 250 ML NS IVPB; PACLITAXEL 80 MG / 250 ML D5W IVPB; PACLITAXEL 117 MG / 250 ML NS IVPB; PACLITAXEL 159 MG / 250 ML NS IVPB; PACLITAXEL 330 MG / 500 ML NS IVPB; PACLITAXEL135 MG / 250 ML NS IVPB; PACLITAXEL 200 MG / 500 ML NS IVPB; PACLITAXEL 150 MG / 250 ML NS IVPB; PACLITAXEL 130 MG / 250 ML NS IVPB; PACLITAXEL 144 MG / 250 ML NS IVPB; PACLITAXEL 300 MG / 500 ML NS IVPB; PACLITAXEL 120 MG / 250 ML NS IVPB; PACLITAXEL 140 MG / 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALIPLATIN 130 MG / 250 ML D5W IVPB; OXALIPLATIN 140 MG / 250 ml D5W IVPB; OXALIPLATIN 162 MG / 250 ML D5W IVPB; OXALIPLATIN 169 MG / 250 ML D5W IVPB; OXALIPLATIN 90 MG / 500 ML D5W IVPB; OXALIPLATIN 50 MG / 250 ML D5W IVPB; OXALIPLATIN 70 MG / 500 ML D5W IVPB; OXALIPLATIN 40 MG / 250 ML D5W IVPB; OXALIPLATIN 155 MG / 250 ML D5W IVPB; OXALIPLATIN 85 MG / 250 ML D5W IVPB OXALIPLATIN 146 MG / 250 ML D5W IVPB; OXALIPLATIN 246 MG / 500 ML D5W IVPB; OXALIPLATIN 143 MG / 250 ML D5W IVPB; OXALIPLATIN 65 MG / 500 ML D5W IVPB; OXALIPLATIN 80 MG / 500 ML D5W IVPB; OXALIPLATIN 100 MG / 250 ML D5W IVPB; OXALIPLATIN 150 MG / 250 ML D5W IVPB; OXALIPLATIN 125 MG / 250 ML D5W IVPB; OXALIPLATIN 170 MG / 250 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

OPDIVO 200 mg /100 ML NS VPB; OPDIVO 480 mg/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

ONDANSETRON 8 MG / 50 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

NIVOLUMAB 480 MG / 100 ML NS IVPB; NIVOLUMAB 200 mg / 100 ML NS IVPB; NIVOLUMAB 165 mg / 100 ML NS IVPB; NIVOLUMAB 240 mg / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Drug Recall Terminated Historical recordClass II

MITOMYCIN 10 MG /20 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

by Infusion Options, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
June 12, 2019
Reported by FDA
August 21, 2019
Distribution
NY only

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.